SLC10A2 (ASBT / IBAT / ISBT) curation notes

Provenance of this review

Automated deep research is not available in this container, so the literature
synthesis below was assembled by hand from the cached publications in publications/,
the cached Reactome entries, the UniProt record, PANTHER/PAINT donor tracing and
QuickGO comparator queries:

No -deep-research-*.md file was written, per CLAUDE.md (hand-written content must
never be named as a deep-research provider output).

Gene identity

Core transport function

Apical / microvillar localization (the key family contrast)

This is the fact that distinguishes SLC10A2 from its sister SLC10A1 (NTCP), which is
basolateral in hepatocytes.

PAINT confirms the apical/basolateral split at the node level

Donor tracing of the IBA rows (SLC10A2-goa.tsv; donor ids resolved via MGI, RGD and
UniProt):

term PTN node donors
GO:0005886 plasma membrane PTN000040759 mouse Slc10a2 (MGI:1201406), rat Slc10a1 (RGD:3681), rat Slc10a2 (RGD:3682), human SLC10A1 (Q14973), human SLC10A4 (Q96EP9)
GO:0008508 bile acid:sodium symporter activity PTN000040761 rat Slc10a1, rat Slc10a2
GO:0015721 bile acid and bile salt transport PTN000040761 rat Slc10a1, rat Slc10a2
GO:0016324 apical plasma membrane PTN002570923 mouse Slc10a2, rat Slc10a2 only

So PAINT places plasma-membrane residence and Na+/bile-acid symport at ancestral SLC10
nodes shared by both branches, but places the apical location at a sub-node whose
donors are exclusively ASBT orthologues. The mirror-image node in the SLC10A1 review is
PTN002570905, which carries GO:0016323 basolateral plasma membrane with NTCP donors.
The apical/basolateral contrast asserted in the SLC10A1 review is therefore confirmed
from the SLC10A2 side
, and it is explicitly represented in the phylogeny rather than
being an inference.

Tissue distribution

Narrow substrate specificity (contrast with NTCP)

This is the reason the SLC10A1 review's GO:0042908 xenobiotic transport replacement
term is not appropriate for SLC10A2: the same paper that justifies it for the liver
carrier explicitly denies the breadth for the ileal/renal one.

Human loss of function

Pathway position

Curation decisions and their reasoning

  1. 12 GO:0005515 protein binding rows → REMOVE. Ten are HuRI yeast-two-hybrid
    (PMID:32296183), one is BioPlex 3.0 affinity-purification MS (PMID:33961781 — the
    Huttlin Cell 2021 dual proteome-scale network paper, not a focused study of
    SLC10A2), one is the SLC-superfamily interactome survey (PMID:40355756). None assigns
    a molecular function. Per repo policy generic protein binding is removed as
    uninformative rather than marked over-annotated, and removal does not dispute the
    interactions. The two partners that recur are UPK1B, EFNA5, IFITM3, CTXN3, TTMP,
    NRM, CCL4L2, TMEM222, PSENEN, TEX264 (HuRI) and CLPTM1 (O96005) twice, from two
    independent methods; CLPTM1 is a putative lipid scramblase of the ER/Golgi membrane
    and is a frequent companion of membrane proteins in AP-MS, so the reproducibility
    does not by itself license a functional term. Raised in suggested_questions.
  2. Transport and localization rows → ACCEPT. GO:0008508, GO:0015721, GO:0005886,
    GO:0016324, GO:0005902, GO:0016020. The PAINT node placements are all sound (table
    above) and the apical sub-node is correctly ASBT-restricted. GO:0016020 is a broad
    IEA parent of correctly annotated children and is kept.
  3. No MODIFY anywhere. Every term in GOA for this gene is at the right
    granularity. In particular GO:0008508 is not obsolete (checked via OLS), and
    GO:0015125 bile acid transmembrane transporter activity would be an ancestor of
    GO:0008508, so adding it would be redundancy, not coverage.
  4. One NEW term: GO:0098719 sodium ion import across plasma membrane.
  5. Participation. ASBT itself translocates the Na+ ions. This is not a
    substrate/necessity argument: the human protein was voltage-clamped and shown to
    carry charge with a 2:1 Na+:bile acid stoichiometry PMID:9856990, so the sodium
    leg of the symport is work the protein performs, in the same molecular event as the
    bile acid leg. Direction is import into the enterocyte, matching the term
    definition ("from outside of a cell, across the plasma membrane and into the
    cytosol", OLS).
  6. Comparator check (QuickGO, 2026-10-04). Na+-coupled symporters conventionally
    carry a sodium-transport process term alongside their solute term: SLC5A1/SGLT1
    (P13866) has GO:0098719 by IDA; SLC34A1/NaPi-IIa (Q06495) has GO:0098719;
    SLC5A5/NIS (Q92911) has GO:0006814 sodium ion transport by IBA and GO:0035725 by
    IEA. So the term is conventionally applied to exactly this role. Within SLC10 it is
    absent from SLC10A2, SLC10A1 and mouse Slc10a2 alike — a family-level gap rather
    than a cross-family convention, which is the pattern that distinguishes a real
    omission from a convention I had not identified.
  7. Non-redundancy. GO:0098719 is neither an ancestor nor a descendant of GO:0015721
    bile acid and bile salt transport.
  8. GO-CAM check. gocams/index.tsv contains no model for SLC10A2 or Q12908, so no
    curator has already modelled this gene in a different role.
  9. Chose the plasma-membrane-specific import term over the broader GO:0035725 because
    the location and direction are both experimentally established.
  10. No NEW process term for bile acid reclamation / enterohepatic circulation.
    GO has no "enterohepatic circulation" term (OLS search returns nothing in GO), and
    GO:0015721 bile acid and bile salt transport already carries the transport claim at
    the right granularity. Inventing an intestinal-reabsorption process term was not
    pursued: the existing term plus the apical location already encode the reclamation
    step, and a more specific term would be a new-term request without a comparator set
    to anchor it. Raised in suggested_questions instead.

Open items